Examples of using Bone resorption in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Bone resorption increased.
It is an inhibitor of osteoclast-mediated bone resorption.
In this process, both bone resorption and formation occur.
The drug"Raloxifene" has an estrogenic effect that inhibits bone resorption.
Parathormone enhances bone resorption, hence osteoporosis is an early symptom;
By inhibiting osteoclast activity via its specific receptors,salmon calcitonin decreases bone resorption.
These cells are responsible for bone resorption, they resorb boney tissue.
Reduces bone resorption by decreasing osteoclast differentiation and resorbing activity.
Calcitonin is a calciotropic hormone,which inhibits bone resorption by a direct action on osteoclasts.
RANKL is essential for the formation, function and survival of osteoclasts,the sole cell type responsible for bone resorption.
Instead, non-pathological bone resorption, or unknown bone diseases.
Metastatic calcification- secondary to metabolic disease that induces high calcium concentration and/or bone resorption dissolution.
Changes may present as bone resorption, widening of the fracture gap, and other such abnormalities.
Alendronate sodium is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation.
Bazedoxifene decreases bone resorption and reduces biochemical markers of bone turnover to the premenopausal range.
Also, osteopenia of the spine(pathology treatment will be described below)may result from intensive bone resorption and imperfect osteogenesis.
Therefore, bone diseases or problems such as bone resorption can cause excessive phosphates to be released in the dog's bloodstream.
Bone resorption due to malignant disease is characterised by excessive bone resorption that is not balanced with appropriate bone formation.
It inhibits increased loss of calcium from the bones( bone resorption), thus normalising elevated serum calcium levels.
Myeloma cells produce factors which stimulate the activity of the cells regulating the bone destruction activity(osteoclasts) andlead to increased bone resorption.
Ibandronic acid selectively inhibits osteoclast activity,reducing bone resorption and thereby reducing skeletal complications of the malignant disease.
Cases of osteonecrosis of thejaw have been reported, predominantly in cancer patients treated with medicinal products that inhibit bone resorption, such as Zometa see section 4.4.
Long-term animal studies,zoledronic acid inhibits bone resorption without adversely affecting the formation, mineralization or mechanical properties of bone. .
Cases of osteonecrosis of the jaw have been reported, predominantly in cancer patients treated with medicinal products that inhibit bone resorption, including zoledronic acid see section 4.4.
Urinary concentrations of the bone resorption marker CTx(C-terminal telopeptide released from Type I collagen) were significantly reduced in the Bondronat group compared to placebo.
Cases of osteonecrosis of the jaw have been reported, predominantly in cancer patients treated with medicinal products that inhibit bone resorption, such as zoledronic acid see section 4.4.
It inhibits increased loss of calcium from the bones( bone resorption), and prevents bone complications and fractures related to the spread of cancer cells into bone. .
Cases of osteonecrosis of the jaw have been reported,predominantly in cancer patients treated with medicinal products that inhibit bone resorption, such as Zoledronic acid medac see section 4.4.
Potency of the medicinal product that inhibits bone resorption(higher risk for highly potent compounds), route of administration(higher risk for parenteral administration) and cumulative dose of bone resorption therapy.
Therefore, in the absence of clinical data,the product should not be used for direct applications to trabecular bone when transient bone resorption may create a risk of bone fragility.